A ‘Head Spinning’ Year: How US FDA’s Ad Enforcement Blitz Reshaped Drug Promotion

 
• By Sue Sutter
  
perspectives 2026
Hiding under the bed
Biopharma companies should be more cautious, but need not hide under the bed, when it comes to advertising and promotion in 2026. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Pink Sheet Perspectives

More from Marketing & Advertising